TZP-101

DRUG5 trials

Sponsors

Tranzyme, Inc., Norgine

Conditions

Diabetes MellitusGastroparesisPostoperative Ileus

Phase 1

Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Diabetic Gastroparesis

CompletedNCT00639808

Tranzyme, Inc.Diabetes Mellitus, Gastroparesis

Start: 2006-08-31End: 2008-03-31Updated: 2008-03-20

A Study in Healthy Male Subjects Designed to Assess the Mass Balance Recovery and Pharmacokinetics of 14C TZP-101

CompletedNCT01668199

NorginePostoperative Ileus

Start: 2012-02-29End: 2012-03-31Updated: 2012-08-17

Phase 2

Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Severe Diabetic Gastroparesis

CompletedNCT00612014

Tranzyme, Inc.Diabetes Mellitus, Gastroparesis

Start: 2007-10-31End: 2009-03-31Updated: 2012-12-07

Safety and Efficacy of IV Infusion of TZP-101 for POI After Major Open Abdominal Surgery

CompletedNCT00617552

Tranzyme, Inc.Postoperative Ileus

Start: 2007-07-31End: 2008-08-31Updated: 2012-12-07

Phase 3

Study to Evaluate the Safety of Post-Operative TZP-101 (IV Ulimorelin) After Partial Bowel Resection

CompletedNCT01710982

NorginePostoperative Ileus

Start: 2012-02-29End: 2012-04-30Updated: 2024-09-19